Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer.


Tumour anaemia is a common symptom in cancer patients, particularly in those receiving chemotherapy. The aim of the current study was to analyse the impact of haemoglobin levels on the prognosis of patients with primary breast cancer receiving adjuvant chemotherapy. A total of 129 patients were available for analysis. The estimated median five-year overall… (More)


  • Presentations referencing similar topics